Related Experiment Video

Updated: Sep 26, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia

S L Nuttall1, S Heaton, M K Piper

  • 1Department of Clinical Pharmacology, University of Birmingham, Birmingham, UK. s.nuttall@bham.ac.uk

Rheumatology (Oxford, England)
|May 6, 2003
PubMed

Insights

Systemic lupus erythematosus (SLE) patients show increased oxidative stress and inflammation, contributing to an atherogenic lipid profile. These factors may explain the heightened cardiovascular disease risk in women with SLE.

Area of Science:

  • Rheumatology
  • Cardiology
  • Biochemistry

Background:

  • Systemic lupus erythematosus (SLE) is linked to premature cardiovascular disease (CVD) beyond traditional risk factors.
  • Understanding non-traditional risk factors is crucial for managing SLE patients.

Purpose of the Study:

  • To investigate oxidative stress, lipid metabolism, and inflammation markers in women with SLE.
  • To identify potential cardiovascular risk factors specific to SLE.

Main Methods:

  • Analysis of venous blood samples from 53 female Caucasian SLE patients and healthy controls.
  • Assessed markers of oxidative stress, lipid profile (including LDL subfractions), and C-reactive protein (CRP).

Main Results:

  • SLE patients exhibited an atherogenic lipid profile: higher total cholesterol and triglycerides.
  • Presence of small, dense LDL subfractions was noted in SLE patients.
  • Increased oxidative damage and moderately elevated CRP levels were observed in SLE patients.

Conclusions:

  • Findings indicate significant free radical activity and inflammation in SLE.
  • These processes likely contribute to the elevated cardiovascular risk in SLE.
  • Potential therapeutic targets for reducing CVD risk in SLE patients were suggested.
Abstract

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...